New AI technology helps pathologists spot cancer
1 Mar, 2022
Back
By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.
Back
By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.
About IBEX
IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis.
Our Galen™ platform is deployed worldwide, supporting pathologists and providers with
AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.
Subscribe to our newsletter:
By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.
About IBEX
IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis.
Our Galen™ platform is deployed worldwide, supporting pathologists and providers with
AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.
Subscribe to our newsletter:
By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.